News & Events Press Releases Events & Presentations Year None20182017 08.09 2018 Translate Bio Announces Second Quarter 2018 Financial Results and Highlights Recent Development and Corporate Achievements 07.09 2018 Translate Bio Announces Closing of Collaboration and Licensing Agreement with Sanofi Pasteur to Develop mRNA Vaccines for Infectious Diseases 06.27 2018 Translate Bio Announces Pricing of Initial Public Offering 06.18 2018 Translate Bio Launches Proposed Initial Public Offering 06.11 2018 Translate Bio Announces Agreement with Sanofi Pasteur to Develop Vaccines for Infectious Diseases using Novel mRNA Technology 06.07 2018 Translate Bio to Present Preclinical Data at the 41st Annual European Cystic Fibrosis Conference 05.23 2018 Translate Bio Names John R. Schroer, CFA, Chief Financial Officer 04.12 2018 Translate Bio Announces FDA Clearance to Proceed with Phase 1/2 Clinical Trial in Patients with Cystic Fibrosis (CF) Upcoming Events More events are coming soon. Past Events 06.06 2018 41st Annual European Cystic Fibrosis Conference Conference Website 06.04 2018 BIO International Convention Conference Website 05.09 2018 TIDES 2018 Conference Website 04.24 2018 World Orphan Drug Congress USA Conference Website 11.16 2017 The Cystic Fibrosis Foundation’s Uncork the Cure Conference Website 11.01 2017 North American Cystic Fibrosis Conference Conference Website 10.31 2017 5th International mRNA Health Conference Conference Website 09.27 2017 Discovery on Target – Emerging Oligonucleotide Therapeutics Conference Website 09.26 2017 2nd International Ataxia Research Conference Conference Website 09.23 2017 The 13th Annual Meeting of the Oligonucleotide Therapeutics Society Conference Website
